CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 66 enrolled
Drug / intervention
Micafungindrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02440178
NCT02440178Phase 2Completed
CompareCT.gov

Phase II Trial of Micafungin Prophylaxis During Induction Chemotherapy for Patients With Acute Leukemia

Seoul National University Hospital·interventional·Posted May 12, 2015·Updated Nov 9, 2021

In Brief

A Phase 2 clinical trial evaluating Micafungin for Acute Leukemia. Completed, enrolled 66 participants.

Detailed Summary

The purpose of this study is to determine whether prophylaxis with micafungin is effective in the induction chemotherapy for newly diagnosed acute leukemia patients.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcute Leukemia
Countries--
CollaboratorsAstellas Pharma Inc

Timeline

Phase 2CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 12, 2015
Enrollment StartSep 19, 2015
Primary CompletionJun 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 11.1 years ago

Interventions

Micafungindrug